Gamida Cell's Corporate Minority Round

Gamida Cell raised a round of funding on October 12, 2015. Investors include Novartis.

Gamida Cell is a provider in stem cell expansion technologies and therapeutic products. The company is developing a pipeline of cell therapeutics to effectively treat debilitating and often fatal illn…

Articles about Gamida Cell's Corporate Minority Round: